Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion

Mayowa A. Osundiji, Daniel D. Lam, Jill Shaw, Chen-Yu Yueh, S. Pauliina Markkula, Paul Hurst, Carolina Colliva, Aldo Roda, Lora K. Heisler, Mark L. Evans*

*Corresponding author for this work

Research output: Contribution to journalArticle

40 Citations (Scopus)
4 Downloads (Pure)

Abstract

As patients decline from health to type 2 diabetes, glucose-stimulated insulin secretion (GSIS) typically becomes impaired. Although GSIS is driven predominantly by direct sensing of a rise in blood glucose by pancreatic beta-cells, there is growing evidence that hypothalamic neurons control other aspects of peripheral glucose metabolism. Here we investigated the role of the brain in the modulation of GSIS. To examine the effects of increasing or decreasing hypothalamic glucose sensing on glucose tolerance and insulin secretion, glucose or inhibitors of glucolcinase, respectively, were infused into the third ventricle during intravenous glucose tolerance tests (IVGTTs). Glucose-infused rats displayed improved glucose handling, particularly within the first few minutes of the IVGTT, with a significantly lower area under the excursion curve within the first 10 min (AUC(0-10))). This was explained by increased insulin secretion. In contrast, infusion of the glucokinase inhibitors glucosarnine or mannoheptulose worsened glucose tolerance and decreased GSIS in the first few minutes of IVGTT. Our data suggest a role for brain glucose sensors in the regulation of GSIS, particularly during the early phase. We propose that pharmacological agents targeting hypothalamic glucose-sensing pathways may represent novel therapeutic strategies for enhancing early phase insulin secretion in type 2 diabetes. Diabetes 61:321-328, 2012

Original languageEnglish
Pages (from-to)321-328
Number of pages8
JournalDiabetes
Volume61
Issue number2
Early online date30 Dec 2011
DOIs
Publication statusPublished - Feb 2012

Keywords

  • in-vivo
  • beta-cells
  • rat-brain
  • glucokinase
  • hypoglycemia
  • plasma
  • homeostasis
  • impairment
  • expression
  • responses

Cite this

Osundiji, M. A., Lam, D. D., Shaw, J., Yueh, C-Y., Markkula, S. P., Hurst, P., ... Evans, M. L. (2012). Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion. Diabetes, 61(2), 321-328. https://doi.org/10.2337/db11-1050

Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion. / Osundiji, Mayowa A.; Lam, Daniel D.; Shaw, Jill; Yueh, Chen-Yu; Markkula, S. Pauliina; Hurst, Paul; Colliva, Carolina; Roda, Aldo; Heisler, Lora K.; Evans, Mark L.

In: Diabetes, Vol. 61, No. 2, 02.2012, p. 321-328.

Research output: Contribution to journalArticle

Osundiji, MA, Lam, DD, Shaw, J, Yueh, C-Y, Markkula, SP, Hurst, P, Colliva, C, Roda, A, Heisler, LK & Evans, ML 2012, 'Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion', Diabetes, vol. 61, no. 2, pp. 321-328. https://doi.org/10.2337/db11-1050
Osundiji, Mayowa A. ; Lam, Daniel D. ; Shaw, Jill ; Yueh, Chen-Yu ; Markkula, S. Pauliina ; Hurst, Paul ; Colliva, Carolina ; Roda, Aldo ; Heisler, Lora K. ; Evans, Mark L. / Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion. In: Diabetes. 2012 ; Vol. 61, No. 2. pp. 321-328.
@article{de98120fb3454039b9470695be5e85e5,
title = "Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion",
abstract = "As patients decline from health to type 2 diabetes, glucose-stimulated insulin secretion (GSIS) typically becomes impaired. Although GSIS is driven predominantly by direct sensing of a rise in blood glucose by pancreatic beta-cells, there is growing evidence that hypothalamic neurons control other aspects of peripheral glucose metabolism. Here we investigated the role of the brain in the modulation of GSIS. To examine the effects of increasing or decreasing hypothalamic glucose sensing on glucose tolerance and insulin secretion, glucose or inhibitors of glucolcinase, respectively, were infused into the third ventricle during intravenous glucose tolerance tests (IVGTTs). Glucose-infused rats displayed improved glucose handling, particularly within the first few minutes of the IVGTT, with a significantly lower area under the excursion curve within the first 10 min (AUC(0-10))). This was explained by increased insulin secretion. In contrast, infusion of the glucokinase inhibitors glucosarnine or mannoheptulose worsened glucose tolerance and decreased GSIS in the first few minutes of IVGTT. Our data suggest a role for brain glucose sensors in the regulation of GSIS, particularly during the early phase. We propose that pharmacological agents targeting hypothalamic glucose-sensing pathways may represent novel therapeutic strategies for enhancing early phase insulin secretion in type 2 diabetes. Diabetes 61:321-328, 2012",
keywords = "in-vivo, beta-cells, rat-brain, glucokinase, hypoglycemia, plasma, homeostasis, impairment, expression, responses",
author = "Osundiji, {Mayowa A.} and Lam, {Daniel D.} and Jill Shaw and Chen-Yu Yueh and Markkula, {S. Pauliina} and Paul Hurst and Carolina Colliva and Aldo Roda and Heisler, {Lora K.} and Evans, {Mark L.}",
year = "2012",
month = "2",
doi = "10.2337/db11-1050",
language = "English",
volume = "61",
pages = "321--328",
journal = "Diabetes",
issn = "0012-1797",
publisher = "AMER DIABETES ASSOC",
number = "2",

}

TY - JOUR

T1 - Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion

AU - Osundiji, Mayowa A.

AU - Lam, Daniel D.

AU - Shaw, Jill

AU - Yueh, Chen-Yu

AU - Markkula, S. Pauliina

AU - Hurst, Paul

AU - Colliva, Carolina

AU - Roda, Aldo

AU - Heisler, Lora K.

AU - Evans, Mark L.

PY - 2012/2

Y1 - 2012/2

N2 - As patients decline from health to type 2 diabetes, glucose-stimulated insulin secretion (GSIS) typically becomes impaired. Although GSIS is driven predominantly by direct sensing of a rise in blood glucose by pancreatic beta-cells, there is growing evidence that hypothalamic neurons control other aspects of peripheral glucose metabolism. Here we investigated the role of the brain in the modulation of GSIS. To examine the effects of increasing or decreasing hypothalamic glucose sensing on glucose tolerance and insulin secretion, glucose or inhibitors of glucolcinase, respectively, were infused into the third ventricle during intravenous glucose tolerance tests (IVGTTs). Glucose-infused rats displayed improved glucose handling, particularly within the first few minutes of the IVGTT, with a significantly lower area under the excursion curve within the first 10 min (AUC(0-10))). This was explained by increased insulin secretion. In contrast, infusion of the glucokinase inhibitors glucosarnine or mannoheptulose worsened glucose tolerance and decreased GSIS in the first few minutes of IVGTT. Our data suggest a role for brain glucose sensors in the regulation of GSIS, particularly during the early phase. We propose that pharmacological agents targeting hypothalamic glucose-sensing pathways may represent novel therapeutic strategies for enhancing early phase insulin secretion in type 2 diabetes. Diabetes 61:321-328, 2012

AB - As patients decline from health to type 2 diabetes, glucose-stimulated insulin secretion (GSIS) typically becomes impaired. Although GSIS is driven predominantly by direct sensing of a rise in blood glucose by pancreatic beta-cells, there is growing evidence that hypothalamic neurons control other aspects of peripheral glucose metabolism. Here we investigated the role of the brain in the modulation of GSIS. To examine the effects of increasing or decreasing hypothalamic glucose sensing on glucose tolerance and insulin secretion, glucose or inhibitors of glucolcinase, respectively, were infused into the third ventricle during intravenous glucose tolerance tests (IVGTTs). Glucose-infused rats displayed improved glucose handling, particularly within the first few minutes of the IVGTT, with a significantly lower area under the excursion curve within the first 10 min (AUC(0-10))). This was explained by increased insulin secretion. In contrast, infusion of the glucokinase inhibitors glucosarnine or mannoheptulose worsened glucose tolerance and decreased GSIS in the first few minutes of IVGTT. Our data suggest a role for brain glucose sensors in the regulation of GSIS, particularly during the early phase. We propose that pharmacological agents targeting hypothalamic glucose-sensing pathways may represent novel therapeutic strategies for enhancing early phase insulin secretion in type 2 diabetes. Diabetes 61:321-328, 2012

KW - in-vivo

KW - beta-cells

KW - rat-brain

KW - glucokinase

KW - hypoglycemia

KW - plasma

KW - homeostasis

KW - impairment

KW - expression

KW - responses

U2 - 10.2337/db11-1050

DO - 10.2337/db11-1050

M3 - Article

VL - 61

SP - 321

EP - 328

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 2

ER -